Business Wire

Kestra Medical Technologies Receives FDA Premarket Approval for ASSURE Wearable Cardioverter Defibrillator (WCD)

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra ™ Medical Technologies, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) Premarket Approval for the ASSURE ® Wearable ...
Seeking Alpha

Largest Real-World Study of Wearable Defibrillators Confirms Strong Effectiveness and Safety Performance of Kestra’s ASSURE Device

KIRKLAND, Wash., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ASSURE ® ...
Business Wire

Kestra Medical Technologies Surpasses 100 Million Covered Lives for ASSURE Wearable Cardioverter Defibrillator (WCD) System

KIRKLAND, Wash.--(BUSINESS WIRE)--Kestra Medical Technologies announced today that the ASSURE ® Wearable Cardioverter Defibrillator (WCD) system is now available in-network to over 100 million ...
Houston Chronicle

All 37 Klein ISD schools have defibrillators

The availability of automated external defibrillators throughout the Klein school district demonstrates the district's commitment to the health and safety of its students and staff, said Laurie Combe, ...
The New England Journal of Medicine

Defibrillation Strategies for Refractory Ventricular Fibrillation

Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...